Rob Freishtat

Board Member at Foundation for mRNA Medicines

Speaker

Dr. Rob Freishtat is a highly regarded physician-executive known for his impact on biotechnology ventures, clinical medicine, and international healthcare initiatives. With a professional history spanning over two decades, Dr. Freishtat has consistently demonstrated his ability to lead high-stakes organizational transformations, drive clinical solutions to the marketplace, and forge strategic global partnerships. As Co-Founder and President of Uncommon Cures, a role he completed in 2025, he revolutionized rare disease clinical trials with innovative models that accelerated trial timelines and slashed costs. Prior to founding Uncommon Cures, Dr. Freishtat was a successful NIH-funded physician-scientist for over 20 years and served in a variety of clinical and research leadership roles. His impact extends to philanthropy, establishing a premier pediatric medical program in Haiti. Dr. Freishtat's business focus is on innovation, strategic growth, and operational excellence.